Fucoidan ingredient specialist Marinova has been named Australia's most outstanding contributor to international health in its home nation's prestigious Australian Export Awards.
Australia's largest and longest running export awards programme was recently held at Parliament House in Canberra, highlighting excellence across 14 different categories.
The International Health category showcases ‘outstanding success in the fields of health, medical or wellbeing’, celebrating Australia’s most innovative exporters in the fields of biotechnology, biosecurity, medical technology, digital health, e-health, aged care, disability, complementary health, pharmaceuticals and related services.
Marinova exports its unique range of bioactive fucoidan ingredients to more than 40 countries across the globe.
Sustainably sourced and clinically validated, Maritech organic fucoidans are sought after by some of the world's most trusted healthcare brands for inclusion in market-leading nutritional supplements, functional foods and beverages, skincare formulations, and animal health products.
The company also supplies high purity fucoidan compounds for global pharmaceutical research.
The Australian Minister for Trade and Tourism, Senator the Honourable Don Farrell, said: "Australia’s exporters make a significant contribution to Australia’s economic prosperity.
“They create thousands of jobs in our regions and cities, taking the best of Australia to the world and enhancing our reputation as a strong and trusted trading nation and partner."
Accepting the award, Marinova's business development manager, Rod Shelley (pictured, left, with marketing manager Amanda Mackinnon), said: "As the world leader in fucoidan science, Marinova specialises in the research, development and production of highly bioactive seaweed extracts for the betterment of human health.
"All our team members share a genuine drive for manufacturing products of superior quality with exceptional scientific credentials. We are delighted to be recognised as Australia's leading innovator in the international health category.”
